Abstract
Selection of T cell-directed immunization strategies is based extensively on discordant information derived from preclinical models. We characterized the kinetics of T cell selection in response to repeated antigenic challenge. By enumerating with epitope/HLA tetrameric complexes (tHLA) vaccine-elicited T cell precursor frequencies (Tc-pf) in melanoma patients exposed to the modified gp100 epitope gp100:209-217 (g209-2M) we observed in most patients that the Tc-pf increased with number of immunizations. One patient's kinetics were further characterized. Dissociation kinetics of g209-2M/tHLA suggested enrichment of T cell effector populations expressing TCR with progressively higher affinity. Furthermore, vaccine-elicited T cells maintained the ability to express IFN-gamma ex vivo and proliferate in vitro. Thus, repeated exposure to immunogenic peptides benefited immune competence. These results provide a rationale for immunization strategies.
MeSH terms
-
Cancer Vaccines / administration & dosage*
-
Cancer Vaccines / immunology*
-
Clone Cells
-
Dose-Response Relationship, Immunologic
-
Down-Regulation / immunology
-
Epitopes, T-Lymphocyte / immunology*
-
Epitopes, T-Lymphocyte / metabolism
-
HLA Antigens / analysis
-
Humans
-
Immunization Schedule
-
Kinetics
-
Ligands
-
Lymphocyte Activation
-
Lymphocyte Count
-
Melanoma / immunology
-
Membrane Glycoproteins / administration & dosage
-
Membrane Glycoproteins / immunology
-
Neoplasm Proteins / administration & dosage
-
Neoplasm Proteins / immunology
-
Peptide Fragments / administration & dosage
-
Peptide Fragments / immunology
-
Peptides
-
Protein Binding / immunology
-
Receptors, Antigen, T-Cell / metabolism*
-
Stem Cells / immunology
-
Stem Cells / metabolism
-
Stem Cells / pathology
-
T-Lymphocytes / immunology
-
T-Lymphocytes / metabolism*
-
T-Lymphocytes / pathology
-
Tumor Cells, Cultured
-
gp100 Melanoma Antigen
Substances
-
Cancer Vaccines
-
Epitopes, T-Lymphocyte
-
HLA Antigens
-
Ligands
-
Membrane Glycoproteins
-
Neoplasm Proteins
-
PMEL protein, human
-
Peptide Fragments
-
Peptides
-
Receptors, Antigen, T-Cell
-
g209-2M melanoma peptide
-
gp100 Melanoma Antigen